Shandong Sanyuan Biotechnology Co.Ltd. (301206) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.006x

Based on the latest financial reports, Shandong Sanyuan Biotechnology Co.Ltd. (301206) has a cash flow conversion efficiency ratio of 0.006x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥24.79 Million ≈ $3.63 Million USD) by net assets (CN¥4.31 Billion ≈ $631.41 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Shandong Sanyuan Biotechnology Co.Ltd. balance sheet independence to measure how much of total assets are equity-financed.

Shandong Sanyuan Biotechnology Co.Ltd. - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Shandong Sanyuan Biotechnology Co.Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Shandong Sanyuan Biotechnology Co.Ltd. to evaluate the quality of earnings relative to operating cash generation.

Shandong Sanyuan Biotechnology Co.Ltd. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shandong Sanyuan Biotechnology Co.Ltd. ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Suzhou Etron Technologies Co Ltd
SHG:603380
0.091x
Shakti Pumps (India) Limited
NSE:SHAKTIPUMP
-0.294x
Logistea AB Series B
ST:LOGI-B
0.003x
Time Publishing and Media Co Ltd Class A
SHG:600551
-0.006x
Beijing Water Business Doctor
SHE:300055
0.001x
Tianma Bearing Group Co Ltd
SHE:002122
0.003x
Appotronics Corp Ltd
SHG:688007
0.032x
Pilkington Deutschland AG
HM:FDD
N/A

Annual Cash Flow Conversion Efficiency for Shandong Sanyuan Biotechnology Co.Ltd. (2013–2024)

The table below shows the annual cash flow conversion efficiency of Shandong Sanyuan Biotechnology Co.Ltd. from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see Shandong Sanyuan Biotechnology Co.Ltd. (301206) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥4.49 Billion
≈ $657.20 Million
CN¥-13.65 Million
≈ $-2.00 Million
-0.003x -124.06%
2023-12-31 CN¥4.54 Billion
≈ $664.06 Million
CN¥57.31 Million
≈ $8.39 Million
0.013x -30.75%
2022-12-31 CN¥4.62 Billion
≈ $676.16 Million
CN¥84.26 Million
≈ $12.33 Million
0.018x -97.03%
2021-12-31 CN¥1.05 Billion
≈ $152.96 Million
CN¥642.08 Million
≈ $93.96 Million
0.614x +44.09%
2020-12-31 CN¥509.91 Million
≈ $74.62 Million
CN¥217.37 Million
≈ $31.81 Million
0.426x -0.54%
2019-12-31 CN¥348.15 Million
≈ $50.95 Million
CN¥149.21 Million
≈ $21.83 Million
0.429x +17.53%
2018-12-31 CN¥179.52 Million
≈ $26.27 Million
CN¥65.46 Million
≈ $9.58 Million
0.365x +108.57%
2017-12-31 CN¥115.81 Million
≈ $16.95 Million
CN¥20.25 Million
≈ $2.96 Million
0.175x -34.01%
2016-12-31 CN¥86.64 Million
≈ $12.68 Million
CN¥22.96 Million
≈ $3.36 Million
0.265x +17.99%
2015-12-31 CN¥42.30 Million
≈ $6.19 Million
CN¥9.50 Million
≈ $1.39 Million
0.225x +86.87%
2014-12-31 CN¥26.60 Million
≈ $3.89 Million
CN¥3.20 Million
≈ $467.64K
0.120x -19.43%
2013-12-31 CN¥26.08 Million
≈ $3.82 Million
CN¥3.89 Million
≈ $569.13K
0.149x --

About Shandong Sanyuan Biotechnology Co.Ltd.

SHE:301206 China Confectioners
Market Cap
$694.28 Million
CN¥4.74 Billion CNY
Market Cap Rank
#10406 Global
#2738 in China
Share Price
CN¥23.45
Change (1 day)
+0.99%
52-Week Range
CN¥22.23 - CN¥30.89
All Time High
CN¥80.39
About

Shandong Sanyuan Biotechnology Co.,Ltd. engages in the research and development, production, and sale of erythritol and compound sugar products in China. Its products are used in table sugar, flavored sugar, and beverages; candy and chocolate food; baked food; health food; medical supplies; cosmetic products; chemical products; and other applications. The company exports its products to Europe, t… Read more